Clinical Trial Update: Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of Remicade (infliximab) for early ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Gu Jieruo | Conditions: Spondylitis | Phase 4 | Status: COMPLETED